- Home
- ANIP vs MNR Comparison
ANIP vs MNR Comparison
Compare ANIP & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- MNR
- Stock Information
- Founded
- ANIP 2001
- MNR 2017
- Country
- ANIP United States
- MNR United States
- Employees
- ANIP N/A
- MNR N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- MNR
- Sector
- ANIP Health Care
- MNR
- Exchange
- ANIP Nasdaq
- MNR Nasdaq
- Market Cap
- ANIP 2.0B
- MNR 2.0B
- IPO Year
- ANIP N/A
- MNR 2023
- Fundamental
- Price
- ANIP $92.85
- MNR $12.36
- Analyst Decision
- ANIP Strong Buy
- MNR Strong Buy
- Analyst Count
- ANIP 7
- MNR 4
- Target Price
- ANIP $99.14
- MNR $21.00
- AVG Volume (30 Days)
- ANIP 343.4K
- MNR 310.6K
- Earning Date
- ANIP 11-07-2025
- MNR 11-07-2025
- Dividend Yield
- ANIP N/A
- MNR 22.36%
- EPS Growth
- ANIP N/A
- MNR N/A
- EPS
- ANIP N/A
- MNR 1.95
- Revenue
- ANIP $747,399,000.00
- MNR $930,939,000.00
- Revenue This Year
- ANIP $39.99
- MNR $20.49
- Revenue Next Year
- ANIP $9.57
- MNR $34.68
- P/E Ratio
- ANIP N/A
- MNR $6.32
- Revenue Growth
- ANIP 38.68
- MNR 11.58
- 52 Week Low
- ANIP $52.50
- MNR $11.79
- 52 Week High
- ANIP $99.50
- MNR $19.00
- Technical
- Relative Strength Index (RSI)
- ANIP 51.08
- MNR 42.65
- Support Level
- ANIP $90.06
- MNR $12.24
- Resistance Level
- ANIP $96.99
- MNR $13.01
- Average True Range (ATR)
- ANIP 2.63
- MNR 0.33
- MACD
- ANIP 0.06
- MNR 0.06
- Stochastic Oscillator
- ANIP 55.91
- MNR 46.36
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.